Other Publications Referenced in Amarin’s Investor Communications ≪ Back to Publications To search publications using the available search words, please click here: The road to approval: a perspective on the role of icosapent ethyl in cardiovascular risk reduction. Wang X, Verma S, Mason RP, Bhatt DL. The road to approval: a perspective on the role of icosapent ethyl in cardiovascular risk reduction. Curr Diabetes Rep. 2020;20:65. https://link.springer.com/content/pdf/10.1007/s11892-020-01343-7.pdf cholesterol data monitoring committee diabetes icosapent ethyl interim analyses IPE mechanism of action REDUCE-IT trial
The road to approval: a perspective on the role of icosapent ethyl in cardiovascular risk reduction. Wang X, Verma S, Mason RP, Bhatt DL. The road to approval: a perspective on the role of icosapent ethyl in cardiovascular risk reduction. Curr Diabetes Rep. 2020;20:65. https://link.springer.com/content/pdf/10.1007/s11892-020-01343-7.pdf cholesterol data monitoring committee diabetes icosapent ethyl interim analyses IPE mechanism of action REDUCE-IT trial